MEDIPOST Co., Ltd. (KOSDAQ:078160)
South Korea flag South Korea · Delayed Price · Currency is KRW
10,210
-240 (-2.30%)
Jun 12, 2026, 3:30 PM KST

MEDIPOST Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
73,89673,65770,65768,64364,20154,856
Other Revenue
----0--
73,89673,65770,65768,64364,20154,856
Revenue Growth (YoY)
2.85%4.25%2.93%6.92%17.03%12.81%
Cost of Revenue
27,00028,22026,51928,45925,82822,994
Gross Profit
46,89645,43644,13840,18438,37331,863
Selling, General & Admin
42,07740,13736,02833,69935,28323,357
Research & Development
73,94171,30954,63629,21619,00411,703
Amortization of Goodwill & Intangibles
246.07246.32574.23473.25466.2431.35
Other Operating Expenses
970.26766.51802.57659.19601.16508.38
Operating Expenses
117,999113,46092,69065,44755,80737,587
Operating Income
-71,103-68,023-48,552-25,263-17,434-5,724
Interest Expense
-5,728-533.2-499.28-6,389-8,276-3,556
Interest & Investment Income
2,8282,1303,4002,5351,4481,225
Earnings From Equity Investments
-2,984-3,818-11,092-4,023-15,081205.04
Currency Exchange Gain (Loss)
-14.98132.891,733132.161,01916.15
Other Non Operating Income (Expenses)
-12,899-23,056-18,32831,88132,5313,693
EBT Excluding Unusual Items
-89,901-93,169-73,339-1,127-5,794-4,141
Gain (Loss) on Sale of Investments
11,9958,82410,7745,59612,2836,193
Gain (Loss) on Sale of Assets
6.2810.31-3.89-54.29-0.82-26.25
Asset Writedown
-1,539-1,539-363.3---1,426
Other Unusual Items
----19.881.66
Pretax Income
-79,438-85,873-62,9314,4146,508602.44
Income Tax Expense
747.56118.57446.1-536.64,4031,569
Earnings From Continuing Operations
-80,186-85,991-63,3774,9512,106-966.42
Minority Interest in Earnings
618.25593.46852.51889.38963.03283.16
Net Income
-79,568-85,398-62,5255,8403,069-683.26
Net Income to Common
-79,568-85,398-62,5255,8403,069-683.26
Net Income Growth
---90.31%--
Shares Outstanding (Basic)
373534201616
Shares Outstanding (Diluted)
373534251916
Shares Change (YoY)
7.63%4.03%34.70%36.23%15.67%3.63%
EPS (Basic)
-2167.93-2407.95-1834.00287.36190.06-42.54
EPS (Diluted)
-2167.93-2407.95-1834.00231.00165.00-43.00
EPS Growth
---40.00%--
Free Cash Flow
-58,551-60,061-39,932-21,638-8,577-6,119
Free Cash Flow Per Share
-1595.31-1693.53-1171.30-854.93-461.66-380.96
Gross Margin
63.46%61.69%62.47%58.54%59.77%58.08%
Operating Margin
-96.22%-92.35%-68.72%-36.80%-27.16%-10.44%
Profit Margin
-107.68%-115.94%-88.49%8.51%4.78%-1.25%
Free Cash Flow Margin
-79.23%-81.54%-56.52%-31.52%-13.36%-11.15%
EBITDA
-65,521-62,037-42,530-19,392-12,052-826.06
EBITDA Margin
-88.67%-84.22%-60.19%-28.25%-18.77%-1.51%
D&A For EBITDA
5,5835,9866,0225,8725,3824,898
EBIT
-71,103-68,023-48,552-25,263-17,434-5,724
EBIT Margin
-96.22%-92.35%-68.72%-36.80%-27.16%-10.44%
Effective Tax Rate
----67.65%260.42%
Advertising Expenses
-2,3971,9871,8561,8431,446